Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs
- PMID: 1730616
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs
Abstract
The amyloid A4 or beta peptide is a major component of extracellular amyloid deposits that are a characteristic feature of Alzheimer's disease. We synthesized a series of peptide analogs of the A4/beta peptide which are progressively longer at their carboxyl termini, including 42- and 39-residue peptides which represent the major forms of the A4/beta peptide in senile plaque and the hereditary cerebral hemorrhage with amyloidosis form, respectively. All peptides tested, beta 1-28 through beta 1-42, formed amyloid-like fibrils and previously unreported thin sheet-like structures which stained with thioflavin T and Congo Red. The solubility of beta 1-42 and shorter peptides was pH and concentration dependent, with a broad insolubility profile in the pH range of 3.5-6.5 and at concentrations above 0.75 mg/ml. Only peptides of 42 residues or longer were significantly insoluble at pH 7.4. beta 1-47 and beta 1-52 peptides are highly insoluble in aqueous media but are soluble at 40 mg/ml in the alpha helix-promoting solvent, 1,1,1,3,3,3-hexafluoro-2-propanol. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed that the beta 1-42 peptide migrates as a series of higher molecular mass aggregates whereas shorter peptides migrate as monomers. Aggregation is also dependent on pH, peptide concentration, and time of incubation in aqueous medium. These results indicate that the length of the hydrophobic carboxyl terminus of the A4/beta peptide is important in determining the solubility and aggregation properties of the A4/beta peptide and that acid pH environment, high peptide concentration, and long incubation time would be predicted to be important factors in promoting amyloid deposition.
Similar articles
-
Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.J Mol Biol. 1991 Mar 5;218(1):149-63. doi: 10.1016/0022-2836(91)90881-6. J Mol Biol. 1991. PMID: 2002499
-
Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides.J Mol Biol. 1992 Nov 20;228(2):460-73. doi: 10.1016/0022-2836(92)90835-8. J Mol Biol. 1992. PMID: 1453457
-
Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.J Mol Biol. 1992 Jun 20;225(4):1075-93. doi: 10.1016/0022-2836(92)90106-t. J Mol Biol. 1992. PMID: 1613791
-
Structural determinants of the Alzheimer's amyloid beta-peptide.J Neurochem. 1994 Oct;63(4):1191-8. doi: 10.1046/j.1471-4159.1994.63041191.x. J Neurochem. 1994. PMID: 7931272 Review.
-
Alzheimer's beta-amyloid: insights into fibril formation and structure from Congo red binding.Subcell Biochem. 2005;38:203-24. doi: 10.1007/0-387-23226-5_10. Subcell Biochem. 2005. PMID: 15709480 Review.
Cited by
-
Thermodynamically stable amyloid-β monomers have much lower membrane affinity than the small oligomers.Front Physiol. 2013 Apr 18;4:84. doi: 10.3389/fphys.2013.00084. eCollection 2013. Front Physiol. 2013. PMID: 23781202 Free PMC article.
-
A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.J Neurosci. 2003 Apr 1;23(7):2665-74. doi: 10.1523/JNEUROSCI.23-07-02665.2003. J Neurosci. 2003. PMID: 12684452 Free PMC article.
-
Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development.Curr Neurol Neurosci Rep. 2002 Sep;2(5):457-64. doi: 10.1007/s11910-002-0073-7. Curr Neurol Neurosci Rep. 2002. PMID: 12169227 Review.
-
Lipid-induced conformational transition of amyloid beta peptide fragments.J Mol Neurosci. 2010 Jul;41(3):368-82. doi: 10.1007/s12031-010-9380-7. Epub 2010 May 18. J Mol Neurosci. 2010. PMID: 20480256
-
Studies on the role of amino acid stereospecificity in amyloid beta aggregation.J Mol Neurosci. 2008;34(1):35-43. doi: 10.1007/s12031-007-0070-z. Epub 2007 Sep 21. J Mol Neurosci. 2008. PMID: 18157656
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical